{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:23:27Z","timestamp":1793413407854,"version":"4.5.0"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2018,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives<\/jats:title>\n                    <jats:p>Literature on the prognosis of patients with cirrhosis who require RRT for AKI is sparse and is confounded by liver transplant eligibility. An update on outcomes in the nonlisted subgroup is needed. Our objective was to compare outcomes in this group between those diagnosed with hepatorenal syndrome and acute tubular necrosis, stratifying by liver transplant listing status.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design, setting, participants, &amp; measurements<\/jats:title>\n                    <jats:p>Retrospective cohort study of patients with cirrhosis acutely initiated on hemodialysis or continuous RRT at five hospitals, including one liver transplant center. Multivariable regression and survival analysis were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Four hundred seventy-two subjects were analyzed (341 not listed and 131 listed for liver transplant). Among nonlisted subjects, 15% (51 of 341) were alive at 6 months after initiating RRT. Median survival was 21 (interquartile range [IQR], 8, 70) days for those diagnosed with hepatorenal syndrome and 12 (IQR, 3, 43) days for those diagnosed with acute tubular necrosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.25). Among listed subjects, 48% (63 of 131) received a liver transplant. Median transplant-free survival was 15 (IQR, 5, 37) days for those diagnosed with hepatorenal syndrome and 14 (IQR, 4, 31) days for those diagnosed with acute tubular necrosis (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =0.60). When stratified by transplant listing, with adjusted Cox models we did not detect a difference in the risk of death between hepatorenal syndrome and acute tubular necrosis (hazard ratio [HR], 0.81; 95% confidence interval [95% CI], 0.59 to 1.11, among those not listed; HR, 0.73; 95% CI, 0.44 to 1.19, among those listed).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cause of AKI was not significantly associated with mortality in patients with cirrhosis who required RRT. Among those not listed for liver transplant, mortality rates were extremely high in patients both with hepatorenal syndrome and acute tubular necrosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Podcast<\/jats:title>\n                    <jats:p>This article contains a podcast at https:\/\/www.asn-online.org\/media\/podcast\/CJASN\/2017_11_09_CJASNPodcast_18_1_A.mp3<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2215\/cjn.03610417","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T20:45:27Z","timestamp":1510260327000},"page":"16-25","source":"Crossref","is-referenced-by-count":150,"title":["Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT"],"prefix":"10.2215","volume":"13","author":[{"given":"Andrew S.","family":"Allegretti","sequence":"first","affiliation":[{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier Vela","family":"Parada","sequence":"additional","affiliation":[{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nwamaka D.","family":"Eneanya","sequence":"additional","affiliation":[{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Gilligan","sequence":"additional","affiliation":[{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihua","family":"Xu","sequence":"additional","affiliation":[{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Zhao","sequence":"additional","affiliation":[{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jules L.","family":"Dienstag","sequence":"additional","affiliation":[{"name":"Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[{"name":"Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi I.","family":"Thadhani","sequence":"additional","affiliation":[{"name":"Division of Nephrology and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,11,9]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1002\/hep.22605","article-title":"Acute kidney injury in cirrhosis.","volume":"48","author":"Garcia-Tsao","year":"2008","journal-title":"Hepatology"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.cgh.2016.09.156","article-title":"Validation of a staging system for acute kidney injury in patients with cirrhosis and association with acute on chronic liver failure.","volume":"15","author":"Huelin","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1053\/j.gastro.2010.07.043","article-title":"Prognostic importance of the cause of renal failure in patients with cirrhosis.","volume":"140","author":"Mart\u00edn-Llah\u00ed","year":"2011","journal-title":"Gastroenterology"},{"key":"B4-20230813","doi-asserted-by":"crossref","first-page":"108139","DOI":"10.1155\/2015\/108139","article-title":"Prognosis of acute kidney injury and hepatorenal syndrome in patients with cirrhosis: A prospective cohort study.","volume":"2015","author":"Allegretti","year":"2015","journal-title":"Int J Nephrol"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"8419719","DOI":"10.1155\/2016\/8419719","article-title":"Population based trends in the incidence of hospital admission for the diagnosis of hepatorenal syndrome: 1998-2011.","volume":"2016","author":"Suneja","year":"2016","journal-title":"Int J Nephrol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1001\/jama.2013.13805","article-title":"The state of US health, 1990-2010: Burden of diseases, injuries, and risk factors.","volume":"310","author":"Murray","year":"2013","journal-title":"JAMA"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1053\/j.gastro.2013.04.005","article-title":"Underestimation of liver-related mortality in the United States.","volume":"145","author":"Asrani","year":"2013","journal-title":"Gastroenterology"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s12072-016-9706-9","article-title":"National trends of acute kidney injury requiring dialysis in decompensated cirrhosis hospitalizations in the United States.","volume":"10","author":"Nadkarni","year":"2016","journal-title":"Hepatol Int"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1681\/ASN.2014020222","article-title":"Association of mortality risk with various definitions of intradialytic hypotension.","volume":"26","author":"Flythe","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1681\/ASN.2010101119","article-title":"Intradialytic hypotension and vascular access thrombosis.","volume":"22","author":"Chang","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/j.1523-1755.2004.00812.x","article-title":"Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients.","volume":"66","author":"Shoji","year":"2004","journal-title":"Kidney Int"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1093\/ndt\/gfg450","article-title":"The effect of frequent or occasional dialysis-associated hypotension on survival of patients on maintenance haemodialysis.","volume":"18","author":"Tisl\u00e9r","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1093\/oxfordjournals.ndt.a092135","article-title":"Cardiac arrhythmias and electrolyte changes during haemodialysis.","volume":"7","author":"Rombol\u00e0","year":"1992","journal-title":"Nephrol Dial Transplant"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1080\/08860220802546495","article-title":"Arrhythmias and hemodialysis: Role of potassium and new diagnostic tools.","volume":"31","author":"Buemi","year":"2009","journal-title":"Ren Fail"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1523-1755.2001.00806.x","article-title":"Cardiac arrest and sudden death in dialysis units.","volume":"60","author":"Karnik","year":"2001","journal-title":"Kidney Int"},{"key":"B16-20230813","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1053\/j.ajkd.2014.02.017","article-title":"Hemodialysis catheter design and catheter performance: A randomized controlled trial.","volume":"64","author":"Van Der Meersch","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"B17-20230813","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1097\/CCM.0b013e3181d454b3","article-title":"Catheter dysfunction and dialysis performance according to vascular access among 736 critically ill adults requiring renal replacement therapy: A randomized controlled study.","volume":"38","author":"Parienti","year":"2010","journal-title":"Crit Care Med"},{"key":"B18-20230813","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/sdi.12224","article-title":"Is there a role for dialysis in patients with hepatorenal syndrome who are not liver transplant candidates?","volume":"27","author":"Belcher","year":"2014","journal-title":"Semin Dial"},{"key":"B19-20230813","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1002\/hep.1840080532","article-title":"Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis.","volume":"8","author":"Schrier","year":"1988","journal-title":"Hepatology"},{"key":"B20-20230813","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMra0809139","article-title":"Renal failure in cirrhosis.","volume":"361","author":"Gin\u00e8s","year":"2009","journal-title":"N Engl J Med"},{"key":"B21-20230813","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2215\/CJN.01340406","article-title":"Hepatorenal syndrome: Pathophysiology and management.","volume":"1","author":"Wadei","year":"2006","journal-title":"Clin J Am Soc Nephrol"},{"key":"B22-20230813","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1007\/s00467-015-3156-9","article-title":"Dialysis-dependent acute kidney injury in children with end-stage liver disease: Prevalence, dialysis modalities and outcome.","volume":"30","author":"Kreuzer","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"B23-20230813","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/lt.24049","article-title":"Outcomes of patients with cirrhosis and hepatorenal syndrome type 1 treated with liver transplantation.","volume":"21","author":"Wong","year":"2015","journal-title":"Liver Transpl"},{"key":"B24-20230813","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1081\/JDI-200035988","article-title":"The clinical course of patients with type 1 hepatorenal syndrome maintained on hemodialysis.","volume":"26","author":"Capling","year":"2004","journal-title":"Ren Fail"},{"key":"B25-20230813","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1136\/pgmj.51.598.515","article-title":"Use of dialysis in the treatment of renal failure in liver disease.","volume":"51","author":"Parsons","year":"1975","journal-title":"Postgrad Med J"},{"key":"B26-20230813","first-page":"287","article-title":"Dialysis in the treatment of renal failure in patients with liver disease.","volume":"8","author":"Wilkinson","year":"1977","journal-title":"Clin Nephrol"},{"key":"B27-20230813","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1440-1746.2004.03471.x","article-title":"Which patients benefit from hemodialysis therapy in hepatorenal syndrome?","volume":"19","author":"Witzke","year":"2004","journal-title":"J Gastroenterol Hepatol"},{"key":"B28-20230813","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1523-1755.2005.00408.x","article-title":"Survival of liver transplant candidates with acute renal failure receiving renal replacement therapy.","volume":"68","author":"Wong","year":"2005","journal-title":"Kidney Int"},{"key":"B29-20230813","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1159\/000334149","article-title":"The challenges of providing renal replacement therapy in decompensated liver cirrhosis.","volume":"33","author":"Gonwa","year":"2012","journal-title":"Blood Purif"},{"key":"B30-20230813","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1097\/00007890-200105270-00012","article-title":"Renal replacement therapy and orthotopic liver transplantation: The role of continuous veno-venous hemodialysis.","volume":"71","author":"Gonwa","year":"2001","journal-title":"Transplantation"},{"key":"B31-20230813","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1046\/j.1523-1755.1998.00004.x","article-title":"Impact of acute renal failure on mortality in end-stage liver disease with or without transplantation.","volume":"54","author":"Fraley","year":"1998","journal-title":"Kidney Int"},{"key":"B32-20230813","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/MEG.0b013e328308bb9c","article-title":"Cirrhotics admitted to intensive care unit: The impact of acute renal failure on mortality.","volume":"21","author":"Cholongitas","year":"2009","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B33-20230813","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1111\/j.1600-6143.2007.01856.x","article-title":"Simultaneous liver-kidney transplantation: Evaluation to decision making.","volume":"7","author":"Davis","year":"2007","journal-title":"Am J Transplant"},{"key":"B34-20230813","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3109\/08860229509026250","article-title":"Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): The role of hemodialysis.","volume":"17","author":"Keller","year":"1995","journal-title":"Ren Fail"},{"key":"B35-20230813","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.2215\/CJN.09600912","article-title":"Short-term pretransplant renal replacement therapy and renal nonrecovery after liver transplantation alone.","volume":"8","author":"Sharma","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"B36-20230813","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/SLA.0000000000001340","article-title":"The evolution of organ allocation for liver transplantation: Tackling geographic disparity through broader sharing.","volume":"262","author":"Axelrod","year":"2015","journal-title":"Ann Surg"},{"key":"B37-20230813","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1001\/jamainternmed.2013.9774","article-title":"A risk prediction score for kidney failure or mortality in rhabdomyolysis.","volume":"173","author":"McMahon","year":"2013","journal-title":"JAMA Intern Med"},{"key":"B38-20230813","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archinternmed.2011.677","article-title":"Association between iodinated contrast media exposure and incident hyperthyroidism and hypothyroidism.","volume":"172","author":"Rhee","year":"2012","journal-title":"Arch Intern Med"},{"key":"B39-20230813","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1053\/j.ajkd.2016.02.041","article-title":"Changes in kidney function after transjugular intrahepatic portosystemic shunts versus large-volume paracentesis in cirrhosis: A matched cohort analysis.","volume":"68","author":"Allegretti","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"B40-20230813","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/gast.2003.50016","article-title":"Model for end-stage liver disease (MELD) and allocation of donor livers.","volume":"124","author":"Wiesner","year":"2003","journal-title":"Gastroenterology"},{"key":"B41-20230813","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jhep.2014.06.012","article-title":"Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure.","volume":"61","author":"Jalan","year":"2014","journal-title":"J Hepatol"},{"key":"B42-20230813","first-page":"1310","article-title":"Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis.","volume":"56","author":"Salerno","year":"2007","journal-title":"Gut"},{"key":"B43-20230813","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites.","volume":"64","author":"Angeli","year":"2015","journal-title":"Gut"},{"key":"B46-20230813","first-page":"CD005162","article-title":"Terlipressin for hepatorenal syndrome.","volume":"9","author":"Gluud","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B47-20230813","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM199908053410603","article-title":"Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis.","volume":"341","author":"Sort","year":"1999","journal-title":"N Engl J Med"},{"key":"B48-20230813","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1002\/hep.27709","article-title":"Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial.","volume":"62","author":"Cavallin","year":"2015","journal-title":"Hepatology"},{"key":"B49-20230813","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1053\/j.gastro.2008.02.024","article-title":"Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: A randomized study.","volume":"134","author":"Mart\u00edn-Llah\u00ed","year":"2008","journal-title":"Gastroenterology"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201801000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:40:58Z","timestamp":1786369258000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201801000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,9]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.03610417","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,9]]}}}